Bite And Itch Lotion
NDC Package 11383-192-01
Package Information
Bite And Itch (diphenhydramine hydrochloride, pramoxine hydrochloride) lotions is usesTemporarily relieves pain and itching due to:scrapessunburnminor cutsminor burnsinsect bitesminor skin irritationspoison ivy, poison oak, or poison sumac. This formulation utilizes a lotion delivery system. Marketed by Weeks & Leo Co., Inc., this product is identified by NDC 11383-192 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1292321 - diphenhydrAMINE HCl 2 % / pramoxine HCl 1 % Topical Lotion
- RxCUI: 1292321 - diphenhydramine hydrochloride 20 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion
- RxCUI: 1292321 - diphenhydramine hydrochloride 2 % / pramoxine hydrochloride 1 % Topical Lotion
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11383 - Weeks & Leo Co., Inc.
- 11383-192 - Bite And Itch
- 11383-192-01 - 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
- 11383-192 - Bite And Itch
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11383-192). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11383-192-01 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Bite And Itch, a human over the counter drug labeled by Weeks & Leo Co., Inc.. This lotion is formulated for cutaneous use and contains diphenhydramine hydrochloride; pramoxine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Weeks & Leo Co., Inc. on June 15, 2015. The current certification is valid through December 31, 2026.
How is this Weeks & Leo Co., Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11383019201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.